Maral Martin Mıldanoğlu

8PUBLICATIONS

25CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGastroenterology and hepatologyChemotherapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 29, 2026

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501).

|May 27, 2026

Prognostic Impact of ABO/Rh Blood Group-Systemic Inflammation Indices Interactions in Small-Cell Lung Cancer.

|May 04, 2026

Combined Lung Immune Prognostic Index (LIPI)-Glasgow Prognostic Score (GPS) as a Prognostic Tool in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy.

|May 04, 2026

A Novel Biological Index for Predicting Neoadjuvant Treatment Response in HER2-Positive Breast Cancer: The Tumor-Immune-Proliferation-Inflammation (TIPI) Score.

|Apr 27, 2026

Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey.

|Mar 28, 2026

Immunotherapy Versus Chemo-Immunotherapy as First-Line Treatment in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Real-World Retrospective Study.

Maral Martin Mildanoglu, Mehmet Haluk Yucel, Ebru Engin Delipoyraz

Pageof 2

Frequent Collaborators

5 joint publications

Ahmet Bilici

4 joint publications

Mehmet Haluk Yucel

4 joint publications

Ebru Engin Delipoyraz

Erdem Sunger

Harun Muglu

Jamshid Hamdard

Özgür Açıkgöz

Sena Fidan

Burcin Cakan Demirel

Yasin Kutlu

Frequent Collaborators

5 joint publications

Ahmet Bilici

4 joint publications

Mehmet Haluk Yucel

4 joint publications

Ebru Engin Delipoyraz

4 joint publications

Erdem Sunger